![](https://www.microbiometimes.com/wp-content/uploads/2018/05/tie-690084_960_720-326x245.jpg)
Finance
Synlogic Announces Leadership Change
Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced that Aoife Brennan, M.B., B.Ch., has accepted the position of Interim President and Chief Executive […]